COST-EFFECTIVENESS ANALYSIS (CEA) BERBAGAI SEDIAAN OBAT ASMA PADA PASIEN ASMA DEWASA DI RSUD KAJEN KABUPATEN PEKALONGAN

  • Ismi Cahya Dhelima Universitas Adhirajasa Reswara Sanjaya
  • Arlette Suzy Puspa Pertiwi Universitas Adhirajasa Reswara Sanjaya
  • Yani Restiani Widjaja Universitas Adhirajasa Reswara Sanjaya
Keywords: Asthma, Cost-Effectiveness Analysis, Average Cost-Effectiveness Ratio, Pharmacoeconomics, Drug Procurement, Hospital Management.

Abstract

Asthma is a chronic inflammatory disease of the airways that requires long-term therapy and contributes to increased healthcare costs. Variations in the use of various asthma medication preparations require evaluation not only of clinical effectiveness and cost, but also as a basis for consideration in drug procurement decisions in hospitals. This study aims to analyze the distribution of use of various asthma medication preparations, clinical effectiveness, direct medical costs, and Cost-Effectiveness Analysis (CEA) results as a basis for consideration in drug procurement decisions at Kajen Regional Hospital, Pekalongan Regency. This study used a qualitative approach with a case study design. Data were obtained through a document review of 64 medical records of adult asthma patients in 2025 and direct medical cost data, as well as in-depth interviews with informants selected using a purposive sampling technique. Document analysis was conducted descriptively to obtain information on the distribution of drug use, clinical effectiveness, direct medical costs, and Average Cost-Effectiveness Ratio (ACER) results. These data were then interpreted, along with interview results, to understand their use in drug procurement decisions. The results showed that nebulized medication preparations were the most widely used. The ICS-LABA inhaler therapy group showed the highest clinical effectiveness with 13 out of 15 patients (86.7%) experiencing no exacerbation and had the lowest ACER value of Rp1,015,998, making it the most cost-effective therapy alternative in this study. SABA inhalers had the lowest average direct medical costs, while nebules had the highest average direct medical costs. Interview results showed that Cost-Effectiveness Analysis information was used as one of the basic considerations in drug procurement decisions while still considering clinical effectiveness, drug safety, compliance with the National Formulary, National Health Insurance provisions, patient needs, drug availability, and hospital budget capabilities. This study concluded that the results of the Cost-Effectiveness Analysis could be one of the supporting information in drug procurement decisions to support more effective, efficient, and evidence-based drug management at Kajen Regional Hospital, Pekalongan Regency.

References

Carreras, M., Goni, M. G., Ibern, P., Coderch, J., Llosera, L., & Inoriza, J. M. (2011). Estimates of patient costs related with population morbidity: Can indirect costs affect the results? European Journal of Health Economics, 12(4), 289–295.
Creswell, J. W., & Poth, C. N. (2018). Qualitative inquiry and research design: Choosing among five approaches (4th ed.). SAGE Publications.
Dhar, R., Ip, M., Kulkarni, T., Kim, S. H., Perng, D. W., Yao, X., et al. (2020). Challenges faced in managing adult asthma: A perspective from Asian countries. Respirology, 25(12), 1235–1242. https://doi.org/10.1111/resp.13899
Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the economic evaluation of health care programmes (4th ed.). Oxford University Press.
Gloria, M. A. J., Thavorncharoensap, M., Chaikledkaew, U., et al. (2024). Systematic review of the impact of health care expenditure on health outcome measures: Implications for cost-effectiveness thresholds. Expert Review of Pharmacoeconomics & Outcomes Research, 24(2), 203–215.
Goldin, J., Hashmi, M. F., & Cataletto, M. E. (2024). Asthma. In StatPearls. StatPearls Publishing.
Hartono, R., Sari, D., & Putri, A. (2022). Analisis manajemen pengadaan obat di instalasi farmasi rumah sakit pemerintah. Jurnal Manajemen Kesehatan Indonesia, 10(2), 120–128.
Kim, Y. M., Kim, Y. S., Jeon, S. G., & Kim, Y. K. (2013). Immunopathogenesis of allergic asthma: More than the Th2 hypothesis. Allergy, Asthma & Immunology Research, 5(4), 189–196.
Kristiningrum, E. (2023). Terapi inhalasi nebulisasi untuk penyakit saluran pernapasan. Cermin Dunia Kedokteran, 50(2), 105–107.
Lorensia, A., & Bahari, F. K. (2020). Analisis efektivitas-biaya antara kombinasi salbutamol-ipratropium dengan salbutamol pada serangan asma. Jurnal Insan Farmasi Indonesia, 3(1), 38–49.
Mbau, R., Musiega, A., Nyawira, L., et al. (2023). Analysing the efficiency of health systems: A systematic review of the literature. Applied Health Economics and Health Policy, 21, 205–224.
Miles, M. B., Huberman, A. M., & Saldaña, J. (2020). Qualitative data analysis: A methods sourcebook (4th ed.). SAGE Publications.
Moleong, L. J. (2021). Metodologi penelitian kualitatif (Edisi revisi). PT Remaja Rosdakarya.
Munaa, N., Ardini, L., & Inayah, Z. (2021). Lean hospital: Strategy of operational financing efficiency in supply chain management. Jurnal Manajemen Kesehatan Indonesia, 9(1), 72–77. https://doi.org/10.14710/jmki.9.1.2021.72-77
Reddel, H. K., Bacharier, L. B., Bateman, E. D., et al. (2022). Global Initiative for Asthma strategy: Executive summary and rationale for key changes. Global Initiative for Asthma.
Published
2026-09-19
How to Cite
Ismi Cahya Dhelima, Arlette Suzy Puspa Pertiwi, & Yani Restiani Widjaja. (2026). COST-EFFECTIVENESS ANALYSIS (CEA) BERBAGAI SEDIAAN OBAT ASMA PADA PASIEN ASMA DEWASA DI RSUD KAJEN KABUPATEN PEKALONGAN. EDU RESEARCH, 7(3), 933-942. https://doi.org/10.47827/jer.v7i3.3717
Section
Articles